OncoMed Pharma (OMED) Misses Q1 EPS by 14c
Tweet
Share
E-mailGet Alerts OMED Hot Sheet
Join SI Premium – FREE
OncoMed Pharma (NASDAQ: OMED) reported Q1 EPS of ($0.49), $0.14 worse than the analyst estimate of ($0.35). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $15.35 million.
For earnings history and earnings-related data on OncoMed Pharma (OMED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Futu Holdings Limited (FUTU) Tops Q2 EPS by 23c
- Alibaba (BABA) Misses Q2 EPS by 220c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
